Sofosbuvir as post-exposure prophylaxis for yellow fever-associated viscerotropic disease (YEL-AVD).

Saved in:
Bibliographic Details
Title: Sofosbuvir as post-exposure prophylaxis for yellow fever-associated viscerotropic disease (YEL-AVD).
Authors: Barrett J; Department of Infection, North Bristol NHS Trust, Bristol, UK., Muntengesa E; Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK., Warrell C; Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK., Rampling T; Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK., Owen J; Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK., Patel D; National Travel Health Network and Centre (NaTHNaC), UCLH NHS Foundation Trust, London, UK., Bhagani S; Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK., Moores R; Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK., Scobie A; Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK.
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2025 Mar 03; Vol. 80 (3), pp. 825-827.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1460-2091
DOI:10.1093/jac/dkae484